Insider Transactions in Q4 2025 at Ovid Therapeutics Inc. (OVID)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Jeremy M Levin CEO |
BUY
Conversion of derivative security
|
Direct |
71,000
+1.89%
|
-
|
|
Dec 08
2025
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,250,000
+15.15%
|
-
|